UBQLN2 and amyotrophic lateral sclerosis: Whiteley and colleagues demonstrated that UBQLN2 facilitates the proteasome-dependent degradation of the PEG10-ORF1/2 protein, and that PEG10-ORF1/2 is specifically upregulated in the spinal cord of ALS patients compared to healthy controls [36,37].